Pentoxifylline Sustained-release Tablets

Name:Pentoxifylline Sustained-release Tablets

Specification：tablets 0.4g

【Approval Number】State Drug Administration H20233310

【Dosage】

The recommended initial dose is one tablet (400 mg) three times daily; in some patients two tablets per day may be sufficient, especially for maintenance therapy, taken with a meal or immediately after a meal with water.

【Indication】

Applicable to peripheral vascular diseases, including intermittent claudication and resting pain.

1. Dilate blood vessels, reduce blood viscosity, multiple effects extreme effectiveness good

2. The first domestic generic drug to pass the quality and efficacy consistency evaluation

3. Slow-release dosage form has fewer adverse reactions and high safety